The Japanese government on March 7 announced new NHI prices for the FY2025 drug price revision, effective April 1. With…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Clinical Research Bill to Make It Easier for Companies to Provide Unapproved Drugs for Clinical Programs: LDP Lawmaker
May 20, 2016
-
REGULATORY Pricy Meds Again a Hot Topic at Chuikyo, MHLW Set to Launch Concrete Discussions
May 19, 2016
-
REGULATORY Chuikyo OKs 16 APIs for Listing on May 25, Novartis’s Melanoma Combo Gets 45% Price Premium
May 18, 2016
-
BUSINESS Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
May 17, 2016
-
BUSINESS As Tagrisso Launch Nears, AZ Pushes Stringent Prerequisites for Facilities, Doctors to Ensure Safety
May 17, 2016
-
ACADEMIA MHLW Study Group Drafting Guidelines for Assessing Cost-Effectiveness of Vaccines Proposed for Inclusion in Public Vaccination Programs
May 16, 2016
-
BUSINESS Daiichi Sankyo Sees 7.3% Sales Rise, but Girding for FY2016 Dip on Olmesartan Cliff
May 13, 2016
-
BUSINESS Ono Delivers Record Sales on Buoyant Opdivo, FY2016 Outlook Tops 250 Billion Yen
May 12, 2016
-
BUSINESS AZ Set to Double Japan Sales by 2020 on Cancer Meds, No Patent Cliff in Sight: Local Pres. Baertschi
May 11, 2016
-
REGULATORY Pharmacists Can Make Big Contribution to Health Finances by Reducing Drug Waste: MHLW Study Group Chief
May 10, 2016
-
ACADEMIA Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
May 9, 2016
-
BUSINESS Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
May 6, 2016
-
BUSINESS Sales Rep Survey - Part 1: Number of Reps at Foreign Drug Makers Declines Sharply; Down by 330 at GSK
May 2, 2016
-
BUSINESS 53 Drug Makers Hire 200 Less New Grads in FY2016, Japan Firms See Hefty Drop: Jiho Tally
April 28, 2016
-
BUSINESS Nogimori to Bow Out as Astellas Chairman
April 28, 2016
-
REGULATORY Chuikyo OKs 7 Drugs Subject to Cost-Effective Review; Re-Pricing to Be Conducted in 2018
April 27, 2016
-
BUSINESS Harvoni Most Prescribed Drug at Acute Hospitals in October-December
April 27, 2016
-
BUSINESS Novartis Looks to Harness Big Data for Indication Expansions: Global Medical Chief
April 26, 2016
-
REGULATORY Making PMDA World’s Most Trusted Regulatory Authority through “Regulatory Innovation”: Chief Executive
April 25, 2016
-
BUSINESS Kaketsuken Continues to Suspend Production as Huge Damages Found
April 22, 2016
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…